The Center for Dementia Research (CDR) is a consortium of independent laboratories and research programs at the Nathan Kline Institute (NKI). Directed by Ralph A. Nixon, Ph.D., M.D., the CDR comprises 7 principal investigators and 50 staff and is dedicated to studies on the pathogenesis, diagnosis, and treatment of AD and other major neurodegenerative diseases. Affiliated with New York University Langone Medical Center (NYULMC), NKI is one of two major institutes for psychiatric research supported in part by the Office of Mental Health of the State of New York. In the 16 years since its establishment at NKI, the CDR has rapidly become an internationally recognized research center, drawing talented and highly respected researchers, technical staff and trainees worldwide, and bringing millions of federal dollars annually to New York to help support its mission. For their work, CDR researchers have received the highest awards bestowed by the National Institutes for Health, the National Alzheimer's Association, and other organizations and publish in the most prestigious journals in science (Cell, PNAS, Nature, Science, Neuron, and others). To learn more about the research performed at our laboratories, please visit our research page.